Core Viewpoint - Centrus Energy has been awarded a $900 million task order by the U.S. Department of Energy to expand its uranium enrichment facility in Piketon, Ohio, which is expected to create thousands of jobs and enhance the U.S. nuclear fuel supply chain [1][2]. Group 1: Expansion and Job Creation - The expansion will support the production of High-Assay, Low-Enriched Uranium (HALEU) and additional Low-Enriched Uranium (LEU) to serve commercial utilities [1][2]. - The project is anticipated to create 1,000 construction jobs and 300 new operating jobs in Ohio, while retaining 150 existing jobs at the Piketon plant [8]. - Additional jobs will be generated at Centrus' centrifuge manufacturing plant in Oak Ridge, Tennessee, and across a nationwide network of suppliers, leading to thousands of indirect jobs [8]. Group 2: Financial Aspects and Commitments - Centrus has secured $2.3 billion in LEU purchase commitments from utilities, contingent upon obtaining necessary financing for the new capacity [4]. - The total task order contract value, including options, is $1.07 billion, with a base amount of $900 million for new enrichment capacity [6]. - The company raised over $1.2 billion in private capital through convertible note transactions to support its expansion plans [4]. Group 3: Technological Development - Centrus has constructed a cascade of advanced centrifuges to demonstrate HALEU production, which became operational in 2023 [3]. - The company plans to build additional centrifuge cascades to enhance HALEU production capacity and produce LEU feed material [4]. Group 4: Government Support and Bipartisan Efforts - The funding award was made possible by a bipartisan funding package supported by various Congressional leaders, highlighting a commitment to revitalizing the U.S. nuclear fuel supply chain [2]. - Centrus' President and CEO expressed gratitude to both Republican and Democratic leaders for their support in securing the funding [2].

Core Viewpoint - The announcement by the U.S. Department of Energy regarding the New Domestic Nuclear Fuel Supply Chain & Uranium Agreement is expected to benefit Terra Clean Energy Corp as it develops its U.S. uranium assets [2][3]. Company Developments - Terra Clean Energy Corp has appointed Jon Li as Chief Financial Officer effective January 1, 2026, following the resignation of Brian Shin [1][3]. - The company is centralizing its operations and management in Toronto [3]. - The annual general meeting held on December 8, 2025, resulted in the re-election of current directors and the election of two additional directors [6]. Industry Context - The U.S. Department of Energy is forming a consortium under the Defense Production Act to enhance the domestic nuclear fuel supply chain, which includes uranium mining and processing [2]. - This initiative aims to reduce reliance on foreign enriched uranium and critical minerals, providing federal incentives and expedited permitting for U.S. uranium projects [2]. Financial and Operational Insights - Jon Li brings over 20 years of finance experience, particularly in the mining and technology sectors, and has served as Vice President at WD Numeric [4][5]. - Terra Clean Energy Corp is developing the South Falcon East uranium project, which has an inferred resource of 6.96 million pounds of uranium within the Fraser Lakes B Deposit in Saskatchewan [9].

Core Viewpoint - The announcement by the U.S. Department of Energy regarding the New Domestic Nuclear Fuel Supply Chain & Uranium Agreement is expected to benefit Terra Clean Energy Corp as it develops its U.S. uranium assets [2][3]. Industry Developments - The U.S. Department of Energy is forming a consortium under the Defense Production Act to enhance the domestic nuclear fuel supply chain, focusing on uranium mining, milling, enrichment, and fuel fabrication [2]. - This initiative aims to reduce reliance on foreign enriched uranium and critical minerals, inviting U.S. companies to participate in the NUCLEAR FUEL CYCLE CONSORTIUM for federal incentives and expedited permitting [2]. Company Developments - Terra Clean Energy Corp has appointed Jon Li as Chief Financial Officer effective January 1, 2026, following the resignation of Brian Shin [1][3]. - The company is centralizing its operations and management in Toronto, which aligns with its strategic goals [3]. - Terra Clean Energy is developing the South Falcon East uranium project, which has an inferred uranium resource of 6.96 million pounds within the Fraser Lakes B Deposit in Saskatchewan, Canada [9]. Management and Governance - The annual general meeting held on December 8, 2025, resulted in the re-election of current directors and the election of two additional directors, Michael Gabbani and Brian Polla [6]. - The appointment of Crowe MacKay LLP as auditors for the year ended December 31, 2024, was ratified by shareholders [6]. Personnel Background - Jon Li has over 20 years of finance experience, particularly in mining, technology, and financial services, and has served as Vice President at WD Numeric [4]. - He is a CPA in both the U.S. and Canada and holds an MBA with a concentration in Accounting [5].

Financial Data and Key Metrics Changes - Total radiopharmaceutical revenues for Q3 2025 were $1.3 million, an 18% increase compared to Q3 2024, and year-to-date revenues reached $3.6 million, a 24% increase versus 2024 [31][32] - Year-to-date total operating expenses increased by $16.5 million, or 84%, from $19.7 million in 2024 to $36.2 million in 2025 [31][32] - Net loss from operations for year-to-date 2025 was $34.9 million, compared to $18.7 million for the same period in 2024 [32][33] - Cash balance as of September 30, 2025, was $113.9 million, reflecting net proceeds of approximately $56 million from common stock issuance during Q3 2025 [34] Business Line Data and Key Metrics Changes - The multi-isotope plant in South Africa is currently enriching silicon-28 and has shipped commercial samples validated for isotopic purity [4][5] - The nuclear medical segment has seen growth in volumes and doses sold, leading to increased revenues [9] - The carbon plant is expected to start producing carbon-14, with the first full batch anticipated in January 2026 [8] Market Data and Key Metrics Changes - The acquisition of Renergen is expected to enhance the company's capabilities in the semiconductor gas vertical, with regulatory approvals nearly complete [5][6] - The company is expanding its radiopharmaceutical operations globally, with the first purchase in the U.S. announced for East Coast Nuclear in Florida [10] Company Strategy and Development Direction - The company aims to secure supply chains of critical materials essential to the U.S. and ASP Isotopes, with recent acquisitions supporting this strategy [21][22] - Quantum Leap Energy (QLE) plans to produce lithium-7 and lithium-6 isotopes to meet the growing demand in the nuclear industry [15][16] - The company is focused on operational de-risking and plans to complete the Renergen acquisition and IPO of QLE in the near future [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational capabilities and customer relationships, emphasizing the positive feedback from customers regarding the silicon-28 enrichment process [38] - The company anticipates significant revenue opportunities in 2026 and 2027, particularly around ytterbium-176 and silicon-28 [49][50] Other Important Information - The company has raised $64.3 million via convertible notes, bringing pro forma cash on hand to $81.6 million [13] - The company is planning to construct new plants in various locations, including Iceland, the U.S., and the U.K., during 2026 [29][30] Q&A Session Summary Question: Can you talk about the delays in shipping Silicon-28? - Delays were due to the complexity of the production process and modifications made after customer visits, which improved the customer-supplier relationship [37][38] Question: When do you expect to achieve operational de-risking in respect of Renergen? - Operational de-risking is expected by the end of Q1 2026, focusing on completing phase 1C of the project [39][40] Question: When will the company begin to recognize revenue in its isotopes enrichment segment? - Revenue recognition for carbon is expected by the end of December 2025, with silicon isotopes anticipated in the first half of 2026 [41][42] Question: What did the customers say about our samples of both Ytterbium and Silicon? - Customers were pleased with the results of the samples, indicating that the technology works effectively [44][47] Question: Can you discuss the revenue opportunity for Ytterbium-176 and Silicon-28? - The company is maintaining previous revenue guidance of $50-$70 million for 2026 and 2027 [49][50] Question: What is the capital commitment for building new facilities in 2026? - Detailed capital commitment information will be provided in future updates [54][55] Question: Can you elaborate on the LEU Plus opportunity? - LEU Plus is a subcategory of HALEU, driven by customer inquiries, aimed at increasing power density and extending the life of nuclear power plants [56][60] Question: Should the $3 million revenue from Skyline Builders be modeled going forward? - The revenue from Skyline Builders is not expected to continue, as the focus will shift to securing the nuclear supply chain [64][66]

Core Viewpoint - NANO Nuclear Energy Inc. has signed a Memorandum of Understanding (MOU) with Dioxitek S.A. to explore opportunities in Argentina's nuclear fuel supply chain, aiming to enhance domestic uranium conversion capabilities and reduce reliance on foreign suppliers [1][2][3]. Group 1: MOU Details - The MOU establishes a non-binding framework for evaluating uranium conversion to enrichment feedstock and supporting infrastructure in Argentina [2]. - NANO Nuclear and Dioxitek will assess the feasibility of collaboration to develop an enrichment production line at Dioxitek's facility [2]. - The collaboration aims to support Argentina's nuclear supply chain and promote the peaceful use of nuclear energy [2]. Group 2: Strategic Importance - Argentina's strategic uranium reserves present an opportunity to address the global uranium hexafluoride (UF₆) shortage by developing domestic conversion capabilities [3]. - The MOU aligns with Argentina's regulatory changes in the nuclear sector, allowing NANO Nuclear to deepen its involvement in the country [3][4]. - The collaboration is expected to contribute to the advancement of Argentina's nuclear infrastructure and fuel cycle capabilities [4][5]. Group 3: Company Background - NANO Nuclear Energy Inc. is focused on becoming a diversified and vertically integrated company across multiple business lines, including nuclear fuel fabrication and transportation [8]. - The company is developing advanced nuclear reactor technologies, including the KRONOS MMR™ Energy System and portable LOKI MMR™ [9][12]. - NANO Nuclear's subsidiary, Advanced Fuel Transportation Inc., aims to build a North American transportation company for HALEU fuel [10].

Financial Data and Key Metrics Changes - Year to date loss from operations was $35.8 million, an increase of approximately $28 million from the comparable nine-month prior year period [43] - Year to date net loss totaled $32 million, up approximately $24 million from the prior year period, reflecting increases in R&D and G&A expenses [44] - Cash and cash equivalents increased to $210.2 million, an approximate $92 million increase from the end of the second fiscal quarter [45] Business Line Data and Key Metrics Changes - The company advanced its patented Cronos MMR energy system toward construction, demonstration, and licensing with the U.S. Nuclear Regulatory Commission (NRC) [20] - A strategic collaboration agreement was executed to build out the first Cronos MMR at the University of Illinois Urbana Champaign [21] - The company signed an MOU with UR America to explore strategic development across Argentina's uranium fuel supply chain [23] Market Data and Key Metrics Changes - Analysts project U.S. electricity consumption to rise at approximately 2.4% CAGR between 2022 and 2030, with data centers expected to comprise 8% of U.S. power by 2030 [12][13] - There is a growing global commitment to triple nuclear capacity by 2050, solidifying growth in nuclear energy as a secular trend for the coming decades [11] Company Strategy and Development Direction - The company is focused on a vertically integrated strategy to derisk microreactor development and enhance its competitive position [6][8] - The acquisition of Cronos MMR microreactor positions the company as a North American leader in microreactor commercialization [6] - The company aims to secure key stages of the nuclear fuel supply chain as a strategic priority [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to capitalize on macro trends driving demand for advanced nuclear solutions [9] - The company highlighted the importance of bipartisan legislative and policy support for nuclear energy, which has emerged as a strategic focus for national security and climate goals [14][15] - Management is optimistic about the future, citing a strong team and a clear vision for commercialization [17] Other Important Information - The company closed a private placement for net proceeds of $99 million, strengthening its balance sheet and expanding institutional ownership [9] - Recent personnel additions and collaborations validate the company's strong competitive position [25][27] Q&A Session Summary Question: Progress in Canada to license there - The company is focused on reengaging with the Canadian licensing process and has almost completed the legal process of taking the holding entity out of bankruptcy [51][52] Question: Commercial sales opportunities for ALIP - The company is completing the SBIR Phase three process with the DOE, which will enable it to become a default contractor for supplying ALIP technology [58] Question: Cash usage during the remainder of 2025 and into 2026 - The estimated cash burn over the next twelve months is around $40 million, primarily for hiring and operational support [68] Question: Strategy of vertical integration - The company is examining how to involve itself in upstream processes like mining, milling, and conversion to derisk the fuel supply chain [75] Question: Application for the DOE Advanced Reactor pilot program - The company did not apply for the DOE program as it would result in higher costs and no commercial benefit [80][82] Question: Supply chain for nuclear grade graphite - The company is negotiating with suppliers for components like nuclear grade graphite and reactor pressure vessels, which will need to be outsourced [87]

Financial Data and Key Metrics Changes - Centrus Energy reported revenue of $73.1 million for Q1 2025, an increase of $29.4 million compared to Q1 2024 [19][20] - The company achieved a net income of $27.2 million, a significant improvement from a net loss of $6.1 million in the same quarter last year [19][20] - Gross profit for the quarter was $32.9 million, compared to $4.3 million in Q1 2024 [19][20] - The cash balance at the end of Q1 2025 was $685.7 million, including $32.7 million of restricted cash [24] Business Line Data and Key Metrics Changes - The LEU segment generated $51.3 million in SWU revenue, an increase of $27.7 million year-over-year, driven by higher volume and average price per SWU sold [20] - The LEU cost of sales for SWU decreased from $23.1 million in Q1 2024 to $20.1 million in Q1 2025, reflecting a 48% decrease in average unit cost [20] - The Technical Solutions segment reported revenue of $21.8 million, up $1.7 million from the previous year, but gross profit decreased to $1.7 million due to delays in obtaining storage cylinders [21][22] Market Data and Key Metrics Changes - The total company backlog was $3.8 billion as of March 31, 2025, with the LEU segment backlog at approximately $2.8 billion [22] - The LEU segment backlog includes $700 million of future SWU and uranium deliveries and $2.1 billion in contingent LEU sales commitments [22] Company Strategy and Development Direction - Centrus aims to secure sufficient public and private capital to expand its enrichment capacity and restore America's uranium enrichment capability [11][19] - The company is pursuing four parallel readiness initiatives, including strengthening its balance sheet and expanding centrifuge manufacturing capacity [12][13] - Centrus emphasizes the importance of reducing dependency on foreign nations and increasing competition in the market for enriched uranium [26][28] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing uncertainty in the global trade environment but reported no impact on operations from tariffs [8][10] - The company is optimistic about the Department of Energy's plans to award $2.7 billion for fuel awards, indicating a positive momentum [31][32] - There is a clear market demand for enriched uranium, particularly for national security purposes and the upcoming advanced reactor markets [18][19] Other Important Information - Centrus is the only company currently enriching uranium with U.S.-owned technology and has a domestic supply chain [7][26] - The company has received political support for its initiatives, with bipartisan backing from local and federal officials [16][17] Q&A Session Summary Question: Update on Department of Energy activity - Management indicated that the DOE is moving quickly and plans to award $2.7 billion, with a lot of activity and momentum observed [31][32] Question: Status of Russian shipment activity - Management confirmed that the process for Russian shipments remains unchanged, with normal business operations continuing [33] Question: Licensing for HALEU production - Management explained that obtaining a HALEU license is a lengthy and costly process, taking years and requiring significant investment [36][37] Question: Timing of SWU and uranium sales - Management noted that customer reloads typically occur every 18 to 24 months, which drives revenue timing [67] Question: Impact of tariffs on customer discussions - Management stated that there have been no disruptions from tariffs, and their supply chain is fully domesticated, reducing exposure compared to competitors [57][58] Question: Dynamics of SWU cost decrease - Management clarified that the 48% decrease in SWU costs was influenced by increased volume and average costing practices [75][77] Question: Competitive landscape for HALEU production - Management highlighted that Centrus is the only facility with a CAT II license for HALEU enrichment, emphasizing their first-mover advantage [80][82]

Financial Data and Key Metrics Changes - Centrus reported revenue of $73.1 million for Q1 2025, an increase of $29.4 million compared to Q1 2024 [18] - The company achieved a net income of $27.2 million, compared to a net loss of $6.1 million in the same quarter last year [18] - Gross profit for the quarter was $32.9 million, significantly up from $4.3 million in Q1 2024 [19] - The cash balance at the end of Q1 2025 was $685.7 million, including $32.7 million of restricted cash [23] Business Line Data and Key Metrics Changes - The LEU segment generated $51.3 million in SWU revenue, an increase of $27.7 million year-over-year [19] - The LEU cost of sales for SWU decreased from $23.1 million in Q1 2024 to $20.1 million in Q1 2025, driven by a 48% decrease in the average unit cost of SWU sold [19][20] - The Technical Solutions segment reported revenue of $21.8 million, up $1.7 million from the previous year, but gross profit decreased to $1.7 million due to delays in obtaining storage cylinders [20][21] Market Data and Key Metrics Changes - The total company backlog was $3.8 billion as of March 31, 2025, with the LEU segment backlog at approximately $2.8 billion [21] - The LEU segment backlog includes $700 million of future SWU and uranium deliveries and $2.1 billion in contingent LEU sales commitments [21] Company Strategy and Development Direction - Centrus aims to secure sufficient public and private capital to expand its enrichment capacity and restore America's uranium enrichment capability [11][24] - The company is pursuing four parallel readiness initiatives, including strengthening its balance sheet and expanding centrifuge manufacturing capacity [12][13] - Centrus emphasizes the importance of reducing dependency on foreign nations and increasing competition in the nuclear energy market [24][26] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing uncertainty in the global trade environment but reported no impact on operations from tariffs [7][10] - The company is confident in its investment case as the only publicly traded enricher capable of meeting commercial and national security needs [11][24] - There is a growing market for enriched uranium, particularly for national security purposes and advanced reactor markets [17] Other Important Information - Centrus has received political support for its initiatives, with bipartisan advocacy for funding to support American jobs and technology [15][16] - The company has a strong first mover advantage in domestic centrifuge production, with all manufacturing conducted in the U.S. [25] Q&A Session Summary Question: Update on Department of Energy activity - Management reported that the DOE is moving quickly and planning to award $2.7 billion, indicating positive momentum [31] Question: Status of Russian shipment activity - There have been no changes in the process, and shipments are proceeding normally without impediments [32] Question: Licensing for HALEU production - Obtaining a HALEU license is a lengthy and costly process, taking years and requiring significant investment [36] Question: Timing of SWU and uranium sales - Management indicated that customer reloads typically occur every 18 to 24 months, which drives revenue timing [68] Question: Impact of tariffs on customer discussions - To date, there have been no impacts from tariffs, and the supply chain remains fully domesticated [57] Question: Competitive landscape for HALEU production - Centrus is currently the only facility with a CAT II license for HALEU enrichment, providing a significant competitive advantage [84]